| STING pathway agonism as a cancer therapeutic BA Flood, EF Higgs, S Li, JJ Luke, TF Gajewski Immunological reviews 290 (1), 24-38, 2019 | 262 | 2019 |
| Tumor heterogeneity and clonal cooperation influence the immune selection of IFN-γ-signaling mutant cancer cells JB Williams, S Li, EF Higgs, A Cabanov, X Wang, H Huang, TF Gajewski Nature Communications 11 (1), 602, 2020 | 102 | 2020 |
| Self-antigen-driven thymic B cell class switching promotes T cell central tolerance J Perera, Z Zheng, S Li, H Gudjonson, O Kalinina, JIC Benichou, KE Block, ... Cell reports 17 (2), 387-398, 2016 | 55 | 2016 |
| Kelch-like protein 14 promotes B-1a but suppresses B-1b cell development S Li, J Liu, Q Min, T Ikawa, S Yasuda, Y Yang, YQ Wang, T Tsubata, ... International immunology 30 (7), 311-318, 2018 | 18 | 2018 |
| Analysis of Ig gene hypermutation in Ung−/− Polh−/− mice suggests that UNG and A: T mutagenesis pathway target different U: G lesions S Li, Y Zhao, JY Wang Molecular Immunology 53 (3), 214-217, 2013 | 8 | 2013 |
| HSP90α deficiency does not affect immunoglobulin gene hypermutation and class switch but causes enhanced MHC class II antigen presentation Y Li, S Li, M Hoshino, R Ishikawa, C Kajiwara, X Gao, Y Zhao, S Ishido, ... International immunology 24 (12), 751-758, 2012 | 5 | 2012 |
| 239 Decr2 loss promotes resistance of tumor cells to immunotherapy by affecting CD8+ T cell-regulated tumor ferroptosis T Gajewski, E Higgs, S Li, B Flood, K Hatogai Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | 3 | 2020 |
| 转录延伸因子 ELL3 在小鼠 B 细胞中的功能研究 李书音 中国农业大学, 2013 | | 2013 |
